Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been seen at a GI clinic, surgery department, or endoscopy unit and doctors suspect or have confirmed that you have a problem with your pancreas (such as a cyst, growth, cancer, or inflammation), based on your symptoms, scans, or blood tests.
- You have not yet had any treatment for your pancreas condition.
- You are able to read and understand the consent form and agree to take part voluntarily.
- You are willing to fill out study questionnaires and allow the researchers to use your medical images and/or samples (such as blood, fluid, or tissue) that are collected during your normal medical care.
Who may not be able to join:
- You do not have any suspected or confirmed pancreas problem (such as a cyst, growth, cancer, or inflammation).
- You have already been diagnosed with a pancreas condition and have already received treatment for it, such as surgery, chemotherapy, immunotherapy, or radiation.
- You are not able to understand or sign the consent form.
- You are not willing to complete the study questionnaires or share your medical samples or images with the researchers.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer Permuth, PhD, Moffitt Cancer Center
Phone: 813-745-6360
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of CT Radiomic features vs conventional radiologic features; Development of Clinical Decision Making Models for Predicting IPMN Pathology; Radiogenomic Analyses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.